scispace - formally typeset
B

Bernd J. Pulverer

Researcher at Ontario Institute for Cancer Research

Publications -  17
Citations -  2311

Bernd J. Pulverer is an academic researcher from Ontario Institute for Cancer Research. The author has contributed to research in topics: Medicine & GSK-3. The author has an hindex of 8, co-authored 12 publications receiving 2239 citations. Previous affiliations of Bernd J. Pulverer include Ludwig Institute for Cancer Research.

Papers
More filters
Journal ArticleDOI

Phosphorylation of c- jun mediated by MAP kinases

TL;DR: Evidence is presented that mitogen-activated protein-serine (MAP) kinases (pp54 and pp42/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.
Journal ArticleDOI

Glycogen synthase kinase-3: functions in oncogenesis and development

TL;DR: Study of GSK-3 had an inauspicious beginning rooted in intermediary metabolism, however, owing to the fortuitous convergence of several disparate areas of biology, the enzyme now offers unique opportunities for study of the control of a variety cellular processes.
Journal Article

Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo

TL;DR: Data suggest acute, post-translational modulation of Myc via phosphorylation of a conserved region previously implicated in transactivation, transformation and autorepression.
Journal Article

Co-purification of mitogen-activated protein kinases with phorbol ester-induced c-Jun kinase activity in U937 leukaemic cells.

TL;DR: A protein kinase activity is detectable in extracts of phorbol ester-treated U937 cells that specifically targets these two serines located within the A1 transactivation domain of c-Jun that have been shown to positively regulate activity.
Journal ArticleDOI

Baculovirus-mediated expression and characterisation of rat glycogen synthase kinase-3β, the mammalian homologue of the Drosophila melanogaster zeste-white 3sgg, homeotic gene product

TL;DR: A rapid purification scheme has been developed yielding essentially pure GSK-3 beta protein in three chromatographic steps, and it is likely that the Drosophila zw3sgg protein kinase has a similar specificity for such transcription factors which may underlie the pleiotropic phenotypes observed when the Dosophila homologue is mutationally inactivated.